Vly News - Professional news Platform

Japanese, Italian, Ukrainian, Swahili, Tagalog, and dozens of other spoken languages ​​cause the same “universal language network” to fire in the brains of native speakers. This language processing center has been studied extensively in English speakers, but now neuroscientists have confirmed that the same network is activated in speakers of 45 different languages ​​representing 12 different language families. “This study is very basic, extending some of the findings from English to multiple languages,” senior author Evelina Fedorenko, a professor of neuroscience at MIT and a member of MIT’s McGovern Institute for Brain Research, said in a statement. statement (opens in a new tab) . “The hope is that now that we see that basic traits seem to be common across languages, we can ask about potential differences between languages ​​and language families in how they are implemented in languages. brain and we can study phenomena that don’t really exist in English,” Fedorenko said. For

A flu vaccine designed to protect against a different strain of virus — and eliminate the annual flu vaccine guessing game — has entered phase 1 clinical trials. A new vaccine candidate, designed to fight avian influenza or bird flu viruses, has been administered to healthy adult volunteers at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland, the NIH announced. Researchers have long sought a universal flu vaccine to fight a rapidly mutating virus — not only to cover our base each flu season but also potentially pre-empt the next pandemic flu strain. “Influenza vaccines that can provide long-term protection against a variety of seasonal influenza viruses as well as those with pandemic potential would be an invaluable public health tool,” said President Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) and Chief Medical Advisor. A new universal flu vaccine candidate is entering human trials to test its safety and imm

ATLANTA—A new universal flu vaccine protects against the influenza B virus, offers broad defense against different strains and enhances immune protection, according to a new study by researchers at Georgia State University’s Institute for Biomedical Sciences. The double-coated protein nanoparticle vaccine, prepared with a stable moiety of the influenza virus (stem hemagglutinin (HA), induces a broad reactive immune response and provides strong and sustained cross-protection against influenza B virus strains of both lineages. The findings are published in the journal. Biomaterials. Influenza epidemics pose a major threat to public health, and influenza type B coincides with several severe flu outbreaks. About a quarter of clinical infections are caused by the influenza B virus each year. Influenza B viruses are sometimes the dominant strain circulating during influenza season, such as the 2019-20 US flu season when influenza B caused more than 50 percent of infections. Influenza B has